Dr Reddy's extends slide as semaglutide setback threatens first-mover edge
Supply disruption has cast doubt on Dr Reddy's ability to capitalise on its early lead, with brokerages warning that prolonged delay could allow competitors to gain ground, weaken pricing power and…
Read the full articleYou might also wanna read
‘We didn’t see this coming’: Wall Street eats its forecasts as stocks sell off globally on fear of AI bubble ahead of SpaceX IPO
Everything you need to know before you reach the office this morning.
OpenAI may delay IPO to 2027 over valuation concerns
CEO Sam Altman reportedly rejected the prospect of lowering the company's $1 trillion valuation target in exchange for a faster listing
qz.com·12d agoThis Stock Stumbled Last Year. Now It's the First Half's Best Performing Mega-Cap Healthcare Stock. Is It Too Late to Buy?
This company's recovery efforts are bearing fruit.
Green Stocks July 6- Green Pack Sees Some Profit Booking
On a day with a firm market, the green pack took a pause as profit booking rose to the fore in many stocks that have risen to highs in the p
PEP Stock Slides Overnight: Wall Street Reconsiders PepsiCo Growth Outlook As Consumer Spending Pressure Dents Prospects
PepsiCo faces cuts to analysts’ price targets as earnings outlook tests investor confidence.
Kospi plunges 8% as AI investors fear rally is overblown; trading halted for 20 mins
South Korea's Kospi index experienced a significant 8% drop, led by chip stocks. Investors questioned the sustainability of record earnings
Kospi plunges 8% as AI investors fear rally is overblown; trading halted for 20 mins
South Korea's Kospi index experienced a significant 8% drop, led by chip stocks. Investors questioned the sustainability of record earnings
Comments
Sign in to join the conversation.
No comments yet. Be the first.